Introduction
Methods
Subjects
Statistical analysis
Results
Low serum amylase (< 60 IU/ml) | Normal to high serum amylase (≥ 60 IU/ml) | P values | |
---|---|---|---|
n | 21 | 33 | – |
Age | 47.1 ± 7.3 | 49.6 ± 7.8 | 0.22 |
Men, n (%) | 17 (81.0) | 27 (81.8) | 0.93 |
Body mass index (kg/m2) | 25.5 ± 3.9 | 23.4 ± 2.6 | 0.04 |
Systolic blood pressure (mmHg) | 119 ± 18.5 | 118 ± 15.0 | 0.88 |
Diastolic blood pressure (mmHg) | 71.9 ± 11.6 | 73.8 ± 11.5 | 0.54 |
Triglyceride (mg/dl) | 117 (88-184) | 92 (76-125) | 0.17 |
HDL-cholesterol (mg/dl) | 55.9 ± 16.1 | 54.8 ± 10.7 | 0.96 |
Creatinine (mg/dl) | 0.8 ± 0.2 | 0.8 ± 0.1 | 0.93 |
eGFR (ml/min/1.73 m2) | 84.8 ± 16.9 | 80.5 ± 11.1 | 0.56 |
Amylase (IU/l) | 49.4 ± 7.6 | 74.6 ± 14.1 | — |
(range) | (32–59) | (60–121) | |
HbA1c (%) (NGSP) | 5.7 ± 0.3 | 5.6 ± 0.3 | 0.47 |
FPG (mg/dl) | 102 ± 11 | 98 ± 7.6 | 0.32 |
PG at 60 min (mg/dl)* | 144 ± 40 | 138 ± 33 | 0.56 |
PG at 120 min (mg/dl)* | 151 ± 44 | 119 ± 35 | 0.004 |
FPI (μU/ml) | 6.0 (3.6–14.9) | 10.3 (5.1–13.1) | 0.30 |
PI at 60 min (μU/ml)* | 32.2 (18.7–62.1) | 55.3 (41.7–86.3) | 0.06 |
PI at 120 min (μU/ml)* | 47.3 (31.6–102) | 45.4 (29.0–65.6) | 0.67 |
HOMA-R | 1.5 (0.9–3.9) | 2.3 (1.2–3.4) | 0.45 |
QUICKI | 0.38 ± 0.10 | 0.34 ± 0.04 | 0.45 |
HOMA-β | 57.6 (34–125) | 104 (54-138) | 0.10 |
Leptin (pg/ml) | 37.3 (18–55) | 27.9 (18–43) | 0.40 |
TNFα (pg/ml) | 0.69 (0.5–1.1) | 0.56 (0.5–0.7) | 0.08 |
Type 2 diabetes† | 4 | 1 | 0.13 |
Current smokers, n (%) | 6 (28.6) | 11 (33.3) | 0.95 |
Everyday alcohol drinkers, n (%) | 10 (47.6) | 9 (27.3) | 0.19 |
Regular exerciser, n (%) | 3 (14.3) | 7 (21.2) | 0.78 |
Amylase | BMI | |
---|---|---|
HOMA-R | –0.006 | 0.47*** |
QUICKI | –0.08 | –0.33* |
HOMA-β | 0.08 | 0.44*** |
Leptin | –0.11 | 0.50*** |
TNFα | –0.18 | 0.24 |
FPI | 0.01 | 0.47*** |
PI at 60 min† | 0.13 | 0.45*** |
PI at 120 min† | –0.09 | 0.50*** |
FPG | –0.23 | 0.28 |
PG at 60 min† | –0.16 | 0.43** |
PG at 120 min† | –0.27 | 0.34* |
HbA1c | –0.13 | 0.43** |
BMI | –0.39** |
1-SD* | Odds ratio (95% CI) | P value | ||
---|---|---|---|---|
BMI | Inc | Model 1 | 2.22 (1.06–4.67) | 0.03 |
Model 2 | 4.41 (1.36–14.3) | 0.01 | ||
HbA1c | Inc | Model 1 | 1.30 (0.74–2.29) | 0.35 |
Model 2 | 1.39 (0.75–2.59) | 0.29 | ||
Model 3 | 0.80 (0.37–1.75) | 0.57 | ||
FPG | Inc | Model 1 | 1.55 (0.87–2.75) | 0.13 |
Model 2 | 1.46 (0.72–2.94) | 0.29 | ||
Model 3 | 1.12 (0.51–2.49) | 0.77 | ||
PG at 60 min† | Inc | Model 1 | 1.18 (0.68–2.06) | 0.55 |
Model 2 | 1.10 (0.56–2.18) | 0.78 | ||
Model 3 | 0.58 (0.23–1.43) | 0.77 | ||
PG at 120 min† | Inc | Model 1 | 2.45 (1.20–4.99) | 0.01 |
Model 2 | 2.55 (1.12–5.80) | 0.03 | ||
Model 3 | 1.78 (0.74–4.27) | 0.20 | ||
FPI | Dec | Model 1 | 1.53 (0.85–2.76) | 0.16 |
Model 2 | 2.18 (0.96–4.98) | 0.06 | ||
Model 3 | 14.9 (2.45–91.0) | 0.003 | ||
PI at 60 min† | Dec | Model 1 | 1.90 (1.02–3.56) | 0.04 |
Model 2 | 3.03 (1.27–7.22) | 0.01 | ||
Model 3 | 11.6 (2.46–54.5) | 0.002 | ||
PI at 120 min† | Dec | Model 1 | 0.83 (0.47–1.45) | 0.51 |
Model 2 | 0.79 (0.39–1.62) | 0.52 | ||
Model 3 | 1.31 (0.56–3.08) | 0.53 | ||
HOMA-R | Dec | Model 1 | 1.45 (0.81–2.58) | 0.21 |
Model 2 | 2.03 (0.91–4.53) | 0.08 | ||
Model 3 | 11.9 (2.13–66.2) | 0.005 | ||
QUICKI | Inc | Model 1 | 1.73 (0.91–3.29) | 0.10 |
Model 2 | 2.67 (1.01–7.07) | 0.048 | ||
Model 3 | 17.3 (2.45–121) | 0.004 | ||
HOMA-β | Dec | Model 1 | 1.79 (0.96–3.34) | 0.07 |
Model 2 | 2.62 (1.08–6.33) | 0.03 | ||
Model 3 | 22.7 (2.87–179) | 0.003 | ||
Leptin | Dec | Model 1 | 0.76 (0.38–1.52) | 0.43 |
Model 2 | 0.88 (0.38–2.03) | 0.77 | ||
Model 3 | 2.45 (0.95–6.35) | 0.06 | ||
TNFα | Inc | Model 1 | 1.54 (0.86–2.76) | 0.15 |
Model 2 | 1.76 (0.86–3.61) | 0.12 | ||
Model 3 | 1.57 (0.70–3.54) | 0.27 |